Mundkur, Mallika L.
Franklin, Jessica
Huybrechts, Krista F.
Fischer, Michael A.
Kesselheim, Aaron S.
Linder, Jeffrey A.
Landon, Joan
Patorno, Elisabetta
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R01HS024930, R01HS024930)
Novo Nordisk Foundation Grant (NNF17SA0027784)
National Institute on Aging (K08AG055670)
Agency for Healthcare Research and Quality (HHSP233201500020I)
Article History
First Online: 9 July 2018
Compliance with Ethical Standards
:
: This study was supported by the Division of Pharmacoepidemiology and Pharmacoeconomics (Brigham and Women’s Hospital, Boston, MA, USA), the Agency for Healthcare Research and Quality R01HS024930 (MAF and JAL) and HHSP233201500020I (JAL). Dr. Kesselheim’s work in this area is supported by CeBIL (Collaborative Research Program for Biomedical Innovation Law), a scientifically independent collaborative research program supported by a Novo Nordisk Foundation Grant (NNF17SA0027784). Dr. Patorno was supported by a career development Grant (K08AG055670) from the National Institute on Aging.
: Mallika L. Mundkur, Jessica Franklin, Krista Huybrechts, Michael A. Fischer, Aaron S. Kesselheim, Jeffrey A. Linder, Joan Landon, and Elisabetta Patorno have no conflicts of interest that are directly relevant to the content of this study.